Abstract

The MLL3 (mixed lineage leukemia 3) protein is a member of the human SET1 family of histone H3 lysine 4 methyltransferases and contains the conserved WDR5 interaction (Win) motif and the catalytic suppressor of variegation, enhancer of zeste, trithorax (SET) domain. The human SET1 family includes MLL1-4 and SETd1A/B, which all interact with a conserved subcomplex containing WDR5, RbBP5, Ash2L, and DPY-30 (WRAD) to form the minimal core complex required for full methyltransferase activity. However, recent evidence suggests that the WDR5 subunit may not be utilized in an identical manner within all SET1 family core complexes. Although the roles of WDR5 within the MLL1 core complex have been extensively studied, not much is known about the roles of WDR5 in other SET1 family core complexes. In this investigation, we set out to characterize the roles of the WDR5 subunit in the MLL3 core complex. We found that unlike MLL1, the MLL3 SET domain assembles with the RbBP5/Ash2L heterodimer independently of the Win motif-WDR5 interaction. Furthermore, we observed that WDR5 inhibits the monomethylation activity of the MLL3 core complex, which is dependent on the Win motif. We also found evidence suggesting that the WRAD subcomplex catalyzes weak H3K4 monomethylation within the context of the MLL3 core complex. Furthermore, solution structures of the MLL3 core complex assembled with and without WDR5 by small angle x-ray scattering show similar overall topologies. Together, this work demonstrates a unique role for WDR5 in modulating the enzymatic activity of the MLL3 core complex.

Highlights

  • The mixed lineage leukemia 3 (MLL3) core complex catalyzes monomethylation of histone H3 lysine 4 (H3K4)

  • Because the WD-40 repeat protein-5 (WDR5) interaction (Win) motif is conserved in all metazoan SET1 family members [21, 23], these results suggest that WDR5 functions to bridge the interaction between the SET1 family SET domain and the retinoblastoma-binding protein-5 (RbBP5)-absent small homeotic-2-like (Ash2L) heterodimer within each core complex, which is critical for formation of the H3K4 dimethylation active site

  • The MLL3 core complex in the presence of WDR5 shows only H3K4 monomethylation activity that is stimulated in comparison with the isolated MLL3 SET domain but is ϳ64-fold slower than the monomethylation rate catalyzed by the MLL1 core complex (Fig. 1D and Table 1)

Read more

Summary

Introduction

The mixed lineage leukemia 3 (MLL3) core complex catalyzes monomethylation of histone H3 lysine 4 (H3K4). Results: The WDR5 subunit is not required for MLL3 core complex assembly and partially inhibits methyltransferase activity. The MLL3 (mixed lineage leukemia 3) protein is a member of the human SET1 family of histone H3 lysine 4 methyltransferases and contains the conserved WDR5 interaction (Win) motif and the catalytic suppressor of variegation, enhancer of zeste, trithorax (SET) domain. The human SET1 family includes MLL1– 4 and SETd1A/B, which all interact with a conserved subcomplex containing WDR5, RbBP5, Ash2L, and DPY-30 (WRAD) to form the minimal core complex required for full methyltransferase activity. We observed that WDR5 inhibits the monomethylation activity of the MLL3 core complex, which is dependent on the Win motif. This work demonstrates a unique role for WDR5 in modulating the enzymatic activity of the MLL3 core complex

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call